Black Diamond Therapeutics Inc – Quartalsfinanzdaten (NASDAQ:BDTX) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Mittelzufluss aus laufender Geschäftstätigkeit -15.05 M53.41 M-9.16 M-7.85 M-6.79 M 29.61 M Mittelzufluss aus Investitionstätigkeit 27.77 M8.55 M-59.15 M8.59 M-2.89 M -44.91 M Zahlungsströme aus der Finanzierungstätigkeit 291 K32 K-116 K134 K-196 K -146 K Freier Cashflow -15.05 M53.41 M-9.16 M-7.85 M-6.79 M 29.61 M

Nachrichten

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

BDTX and Brain Metastases: Why CNS Activity Could Matter in 2026

Black Diamond Stock: Weighing Catalysts vs. Concentration

BDTX: What Silevertinib Data Say About EGFR NSCLC Upside

Black Diamond Therapeutics: Market Yawning About Data, But I See Opportunity (BDTX)

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?

What Makes Black Diamond (BDTX) a New Strong Buy Stock

New Strong Buy Stocks for January 9th

Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)

Black Diamond Therapeutics: Stifel bekräftigt "Buy"-Rating nach vielversprechenden Studiendaten

Stifel reiterates Buy rating on Black Diamond Therapeutics stock at $8